The Legal Ecology of Resistance: The Role of Antibiotic Resistance in Pharmaceutical Innovation
Boston University School of Law
October 21, 2009
Cardozo Law Review, Forthcoming
Boston Univ. School of Law Working Paper No. 09-48
Antibiotic effectiveness is a common pool resource that can be prematurely depleted through resistance. Some experts warn that we may face a global ecological collapse in antibiotic effectiveness.
Conventional wisdom argues for more intellectual property rights to speed the creation of new antibiotics. Recent theoretical literature suggests that conservation-based approaches may yield superior results. This Article describes a novel typology for organizing these emerging theories, and provides an early empirical test of these models, using proprietary data on the sales of vancomycin, an important hospital antibiotic for the last three decades.
The results challenge the assumptions in several models, and will force a reevaluation of the role of intellectual property rights in antibiotic resistance and conservation. In particular, insurance reimbursement may be a more effective policy lever than patent law to preserve antibiotic effectiveness.
Number of Pages in PDF File: 67
Keywords: antibiotic, antimicrobial, resistance, pharmaceutical, innovation, intellectual property, patent, reimbursement, MRSA, public health
JEL Classification: H41, H51, I18, K11, K19, K32, K33Accepted Paper Series
Date posted: October 22, 2009 ; Last revised: February 19, 2014
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo3 in 0.422 seconds